Limited Clinical Value of Anti-Retinal Antibody Titers and Numbers in Autoimmune Retinopathy
Ploysai Rujkorakarn,1– 3 Michael J Margolis,1,2 Diana Morvey,1,2 Yujia Zhou,1,2 C Stephen Foster1,2,4 1Massachusetts Eye Research and Surgery Institution, Waltham, MA, USA; 2The Ocular Immunology and Uveitis Foundation, Waltham, MA, USA; 3Suddhavej Hospital Department of Ophthalmology, Mahasarakham...
Main Authors: | Rujkorakarn P, Margolis MJ, Morvey D, Zhou Y, Foster CS |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-03-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/limited-clinical-value-of-anti-retinal-antibody-titers-and-numbers-in--peer-reviewed-fulltext-article-OPTH |
Similar Items
-
Rituximab Monotherapy versus Rituximab and
Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy
by: Arash Maleki, et al.
Published: (2022-11-01) -
Multifocal Electroretinography in Diabetic Patients without Retinopathy
by: Özgür Balta, et al.
Published: (2018-12-01) -
Objective Determination of Retinal Function in Bietti Crystalline Retinopathy
by: Dorukcan Akıncıoğlu, et al.
Published: (2016-06-01) -
Intravenous Immunoglobulin for Management of Non-paraneoplastic Autoimmune Retinopathy
by: Sahba Fekri, et al.
Published: (2020-04-01) -
Electroretinographic Changes Following Retinal Reattachment Surgery
by: Mohsen Azarmina, et al.
Published: (2013-01-01)